ClearTrial to Present Best Practices for Reducing Clinical Study Costs and Risk at Leading Industry ConferencePresentation will highlight strategies to optimize key cost and schedule drivers for clinical studies, while maintaining study feasibility CHICAGO, IL – April 12, 2011 ClearTrial, the leading provider of software for the planning, forecasting, and tracking of clinical project and financial performance, announced today that Kristin Mauri, Director, Clinical Services at ClearTrial, will present at the upcoming Improved Clinical Development Budgeting, Forecasting and Cost Management Conference in London. As Europe's only industry event focusing on clinical trial budgeting, forecasting and cost management, the conference brings together professionals from clinical operations, finance, and project management to share proven methods for more cost-effective clinical development practices.
"We're pleased to bring our expertise in managing clinical study costs and risk to this important international conference," said Andrew Grygiel, Vice President of Marketing and Product Management for ClearTrial. "According to the Tufts Center for the Study of Drug Development, it now costs approximately $1.3 billion to develop a new drug. With a significant portion of that cost resting with clinical development, we look forward to sharing real-world examples of how sponsors are reducing clinical development cycle-times and costs, while improving operating efficiency." About ClearTrial® ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, an integrated system for clinical operations planning, forecasting, outsourcing, and project tracking. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information visit http://www.cleartrial.com. ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners. For more information contact: Mike Lange |
